Next month is AMD awareness month once more, a chance to further advance research and awareness into this increasingly common condition. What areas of AMD do you need to focus on, as an ophthalmologist? Causes of AMD There are many…
Blue light has been a hot topic in the eye industry for a number of years now, and each year we understand more about how it affects eye health. Exposure to damaging blue light wavelengths is thought to be responsible…
Are patients aware of the risks that artificial blue light poses to eye health? Technology is a huge part of our lives, and people spend on average 6-8 hours per day looking at a screen. Damaging blue light is emitted…
Lutein and zeaxanthin, used as a treatment for age-related macular degeneration, is also being used by professional sportspeople to improve their performance and visual acuity. How does it work? We know that these two nutrients can improve macular pigment optical…
What is the future for AMD patients, and can lutein and zeaxanthin help slow the progression to advanced AMD? Age-related macular degeneration is one of the leading causes of blindness, and researchers are trying to find effective ways to slow…
Macular degeneration is a major problem for an ageing population. Optometry Today’s Nikki Withers investigates the potential of measuring macular pigment to prevent the progression of AMD. FINDING A management strategy to slow down the progression of AMD is something…
With a booming and ageing population, promoting the importance of eye health in the UK has never been more important. National Eye Health Week 2015 has seen some key issues come to both patients and eye health professionals’ attention. Smoking…
Are our modern lifestyles affecting our eyes? We have come across some interesting research by Dr. Stuart Richer, director of ocular preventive medicine at the James Lovell Federal Health Care Facility in Chicago, suggesting ‘bad blue’ light is photochemically damaging…
Leading optometrist Dr Scott Mackie spoke at the Optikmassen workshops in Stockholm on the 28th and 29th August about measuring macular pigment density when screening for macular degeneration (AMD) risk. This officially launched our MPS II screener in Sweden, with…
This white paper was written by Dr. Scott Mackie, a Consultant Ophthalmologist, and is supported by Elektron Technology. The paper suggests and outlines pragmatic guidelines for a coherent strategy around Prevention and Management of AMD. Download here Contents Risk Factors…